| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5328 | Unc10112749a | Novel inhibitor of ROP18, inhibiting ROP18 within cells, and abrogating its effects on the host IRG pathway |
|
| DCC5329 | Unc10245092 | Novel Peptide Inhibitor for Calcium and Integrin Binding Protein 1 (CIB1) |
|
| DCC5330 | Unc1653 | Negative control for UNC1666 which is a dual Mer and Flt-3 tyrosine kinase inhibitor |
|
| DCC5331 | Unc32a | Orally Active Adenosine A 1 Receptor Agonist |
|
| DCC5332 | Unc4859 | Novel Ligand of EEDm acting as an allosteric inhibitor of PRC2 |
|
| DCC5333 | Unc5114 | Novel allosteric inhibitor of PRC2 catalytic activity |
|
| DCC5334 | Unc5115 | Novel allosteric inhibitor of PRC2 catalytic activity |
|
| DCC5335 | Unc5635 | Novel selective activator of PRC2-EED-I363M, showing minimal effects on the activity of PRC2-WT |
|
| DCC5336 | Unc5636 | Novel selective activator of PRC2-EED-I363M, showing minimal effects on the activity of PRC2-WT |
|
| DCC5337 | Unc6212 | Novel inhibitor for histone methyllysine reader proteins (KmeRP), targeting CBX5 chromodomain |
|
| DCC5338 | Unc6349 | Novel inhibitor for histone methyllysine reader proteins (KmeRP), targeting CBX5 chromodomain |
|
| DCC5339 | Unc6641 | Novel peptidomimetic antagonist of the PHF1 Tudor domain, binding both PHF1 Tudor domain and the related protein PHF19 |
|
| DCC5340 | Unc6864 | Novel inhibitor for histone methyllysine reader proteins (KmeRP), targeting CBX5 chromodomain |
|
| DCC5341 | Unc7040 | Novel potent and selective PAM of CBX8, blocking H3K27me3 binding and enhancing CBX8 affinity for nucleic acids, evicting PRC1 from H3K27me3 targets triggering DLBCL cell differentiation |
|
| DCC5342 | Unc9975 | Novel β-arrestin-biased D2 receptor (D2R) agonist |
|
| DCC5343 | Unipr500 Featured | Novel Eph antagonist, inhibiting Eph/ephrin interactions, enhancing glucose-stimulated insulin secretion (GSIS), and acting as a hypoglycemic agent |
|
| DCC5344 | Uodc14 | The first bifunctional (chemoreactive and clickable) probe for Adenosine A1 and A3 Receptors |
|
| DCC5345 | Upf-648 | Potent kynurenine 3-monooxygenase (kynurenine 3-hydroxylase; KMO) inhibitor |
|
| DCC5346 | Upg-100 | Novel superagonist of the urotensin-II (UT) receptor |
|
| DCC5347 | Upg-83 | Novel Potent antagonist of the Urotensin-II (UT) Receptor |
|
| DCC5348 | Upg-92 | Novel superagonist of the urotensin-II (UT) receptor |
|
| DCC5349 | Upg-95 | Novel potent antagonist of the Urotensin-II (UT) receptor |
|
| DCC5350 | Uproleselan | Novel E-Selectin antagonist, disrupting cell survival pathway activation, enhancing chemotherapy response and protecting from toxicity such as mucositis with improved survival in vivo |
|
| DCC5351 | Ur-ak1 | Novel Neuropeptide Y Y4 Receptor (Y4R) Antagonist (pK i values <7.57) |
|
| DCC5352 | Ur-ak32 | Novel Potent Neuropeptide Y Y4 Receptor (Y4R) Partial Agonist (pK i : 8.47) |
|
| DCC5353 | Uralenol-3-methylether | Natural flavonoid from the leaves of Glycyrrhiza uralensis |
|
| DCC5354 | Ur-ap164 | Novel Red-Emitting Fluorescent Dualsteric Probe for the Muscarinic Acetylcholine M2 Receptor |
|
| DCC5355 | Urb524 | Novel FAAH inhibitor |
|
| DCC5356 | Urb532 | Potent, selective, and irreversible inhibitor of fatty acid amide hydrolase (FAAH) |
|
| DCC5357 | Ur-deba148 | Novel potent partial agonist of histamine H4 receptors (H4R) |
|
